The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration - PubMed (original) (raw)
Guideline
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al. J Clin Epidemiol. 2009 Oct.
Free article
Abstract
Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement--a reporting guideline published in 1999--there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (http://www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.
Similar articles
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19622512 - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621070 Free PMC article. - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article. - Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P; PRISMA-Equity Bellagio group. Welch V, et al. J Clin Epidemiol. 2016 Feb;70:68-89. doi: 10.1016/j.jclinepi.2015.09.001. Epub 2015 Sep 5. J Clin Epidemiol. 2016. PMID: 26348799 - The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. Hutton B, et al. Ann Intern Med. 2015 Jun 2;162(11):777-84. doi: 10.7326/M14-2385. Ann Intern Med. 2015. PMID: 26030634
Cited by
- Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature.
Mattiolo P, De Bellis M, Mafficini A, Fassan M, Bevere M, Ciulla C, Bersani S, Lawlor RT, Milella M, Scarpa A, Luchini C, Ruzzenente A. Mattiolo P, et al. J Gastrointest Cancer. 2024 Sep 16. doi: 10.1007/s12029-024-01113-8. Online ahead of print. J Gastrointest Cancer. 2024. PMID: 39283582 - Understanding customer loyalty in banking industry: A systematic review and meta analysis.
Kim L, Jindabot T, Yeo SF. Kim L, et al. Heliyon. 2024 Aug 22;10(17):e36619. doi: 10.1016/j.heliyon.2024.e36619. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281651 Free PMC article. - Systematic review with meta-analysis of intraoperative neuromonitoring during thyroid reoperation.
Ji S, Hu M, Zhang C, Pei M. Ji S, et al. Pak J Med Sci. 2024 Sep;40(8):1860-1866. doi: 10.12669/pjms.40.8.8241. Pak J Med Sci. 2024. PMID: 39281237 Free PMC article. Review. - The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review.
Kohlhoff G, Kirwan R, Mushtaq S. Kohlhoff G, et al. Eur J Nutr. 2024 Sep 14. doi: 10.1007/s00394-024-03489-6. Online ahead of print. Eur J Nutr. 2024. PMID: 39276209 Review. - Impact of electronic medical records on healthcare delivery in Nigeria: A review.
Olukorode SO, Adedeji OJ, Adetokun A, Abioye AI. Olukorode SO, et al. PLOS Digit Health. 2024 Sep 13;3(9):e0000420. doi: 10.1371/journal.pdig.0000420. eCollection 2024 Sep. PLOS Digit Health. 2024. PMID: 39269927 Free PMC article.